Gsa Capital Partners LLP Novavax Inc Call Options Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
309Shares Held
91.7MCall Options Held
6.17MPut Options Held
6.95M-
Vanguard Group Inc Valley Forge, PA15.4MShares$131 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$100 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$97.6 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$57.9 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$32.5 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $663M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...